Skip to main content



) --

Abbott Laboratories



) hit a new 52-week high Tuesday as it is currently trading at $56.90, above its previous 52-week high of $56.84 with 1.1 million shares traded as of 10:40 a.m. ET. Average volume has been 6.4 million shares over the past 30 days.

Abbott has a market cap of $87.21 billion and is part of the

health care

sector and


industry. Shares are up 0.7% year to date as of the close of trading on Monday.

Scroll to Continue

TheStreet Recommends

Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products worldwide. The company has a P/E ratio of 18.8, below the average drugs industry P/E ratio of 19.4 and above the S&P 500 P/E ratio of 17.7.

  • Sign up for TheStreet's FREE Dividend and Income Investor Newsletter

TheStreet Ratings rates Abbott as a


. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, revenue growth, largely solid financial position with reasonable debt levels by most measures, expanding profit margins and solid stock price performance. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. You can view the full

Abbott Ratings Report


See all

52-week high stocks

or get investment ideas from our

investment research center